Hartman Institute for Therapeutic Organ Regeneration

Dedifferentiation of lineage-committed cells by a small molecule.

TitleDedifferentiation of lineage-committed cells by a small molecule.
Publication TypeJournal Article
Year of Publication2004
AuthorsChen S, Zhang Q, Wu X, Schultz PG, Ding S
JournalJ Am Chem Soc
Volume126
Issue2
Pagination410-1
Date Published2004 Jan 21
ISSN0002-7863
KeywordsAdipocytes, Animals, Cell Differentiation, Cell Lineage, Mice, Molecular Weight, Morpholines, Myoblasts, Osteocytes, Purines, Stem Cells
Abstract

Combinatorial libraries were screened for molecules that induce mouse myogenic lineage committed cells to dedifferentiate in vitro. A 2,6-disubstituted purine, reversine, was discovered that induces lineage reversal of C2C12 cells to become multipotent progenitor cells which can redifferentiate into osteoblasts and adipocytes. This and other such molecules are likely to provide new insights into the molecular mechanisms that control cellular dedifferentiation and may ultimately be useful to in vivo stem cell biology and therapy.

DOI10.1021/ja037390k
Alternate JournalJ Am Chem Soc
PubMed ID14719906

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065